A detailed history of Whittier Trust CO transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Whittier Trust CO holds 360 shares of BLUE stock, worth $3,060. This represents 0.0% of its overall portfolio holdings.

Number of Shares
360
Previous 360 -0.0%
Holding current value
$3,060
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 26, 2021

SELL
$16.59 - $33.89 $5,972 - $12,200
-360 Reduced 50.0%
360 $11,000
Q4 2020

Jan 29, 2021

BUY
$27.5 - $37.92 $9,900 - $13,651
360 Added 100.0%
720 $32,000
Q2 2020

Jul 10, 2020

SELL
$27.12 - $45.97 $4,095 - $6,941
-151 Reduced 29.55%
360 $22,000
Q1 2020

Apr 27, 2020

SELL
$26.16 - $63.5 $810 - $1,968
-31 Reduced 5.72%
511 $23,000
Q4 2019

Jan 31, 2020

BUY
$46.96 - $61.67 $6,809 - $8,942
145 Added 36.52%
542 $48,000
Q3 2019

Oct 18, 2019

BUY
$59.47 - $93.1 $2,200 - $3,444
37 Added 10.28%
397 $36,000
Q3 2018

Oct 23, 2018

BUY
$88.86 - $117.49 $31,989 - $42,296
360 New
360 $53,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $656M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.